Literature DB >> 22673112

Genetic variation in galectin-3 gene associates with cognitive function at old age.

Stella Trompet1, Wouter Jukema, Simon P Mooijaart, Ian Ford, David J Stott, Rudi G J Westendorp, Anton J M de Craen.   

Abstract

Inflammation plays an important role in the development of cognitive decline and dementia in old age. Galectin-3 is known for its role in acute and chronic inflammation. We assessed whether genetic variation in the LGALS3 gene, encoding for galectin-3, associates with cognitive function in the 5804 participants of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). The rs4644, rs4652, and rs1009977 polymorphisms were genotyped to cover the genomic region of the LGALS3 gene. Subjects carrying the variant alleles of each LGALS3 single nucleotide polymorphism (SNP) had significantly higher baseline C-reactive protein concentrations (p < 0.01). Carriers of the variant alleles had significantly worse performance at baseline compared with carriers of the wild-type allele (all p < 0.05). In the longitudinal analysis, we found that carriers of the variant alleles had worse performance at the attention tasks compared with carriers of the wild-type allele. Although observed differences were small, these data suggest that genetic variation in the LGALS3 gene might be associated with cognitive function in an elderly population. Further research is warranted to confirm these results.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22673112     DOI: 10.1016/j.neurobiolaging.2012.05.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  16 in total

Review 1.  Integrative biological analysis for neuropsychopharmacology.

Authors:  Mark R Emmett; Roger A Kroes; Joseph R Moskal; Charles A Conrad; Waldemar Priebe; Fernanda Laezza; Anke Meyer-Baese; Carol L Nilsson
Journal:  Neuropsychopharmacology       Date:  2013-06-26       Impact factor: 7.853

2.  Analysis of variants at LGALS3 single nucleotide polymorphism loci in skull base chordoma.

Authors:  Kaibing Tian; Liang Wang; Ke Wang; Junpeng Ma; Da Li; Yang Yang; Guijun Jia; Zhen Wu; Liwei Zhang; Junting Zhang
Journal:  Oncol Lett       Date:  2018-05-22       Impact factor: 2.967

3.  Genetic Variants in the Vicinity of LGALS-3 Gene and LGALS-3 mRNA Expression in Advanced Carotid Atherosclerosis: An Exploratory Study.

Authors:  Ana Djordjevic; Maja Zivkovic; Aleksandra Stankovic; Ivan Zivotic; Igor Koncar; Lazar Davidovic; Dragan Alavantic; Tamara Djuric
Journal:  J Clin Lab Anal       Date:  2016-05-21       Impact factor: 2.352

4.  Relationship between inflammatory biomarker galectin-3 and hippocampal volume in a community study.

Authors:  Megan K Lowther; Jarrod P Tunnell; Jayme M Palka; Darlene R King; Damilola C Salako; Dimitri G Macris; Jay B Italiya; Justin L Grodin; Carol S North; E Sherwood Brown
Journal:  J Neuroimmunol       Date:  2020-09-08       Impact factor: 3.478

5.  Galectin-3 and risk of ischaemic stroke: Reasons for Geographic and Racial Differences in Stroke cohort.

Authors:  P Arora; Z Agarwal; A Venkatraman; P Callas; B M Kissela; N S Jenny; S E Judd; N A Zakai; M Cushman
Journal:  Eur J Neurol       Date:  2017-10-04       Impact factor: 6.089

6.  Galectin-3 and Its Genetic Variation rs4644 Modulate Enterovirus 71 Infection.

Authors:  Wen-Chan Huang; Hung-Lin Chen; Huan-Yuan Chen; Kuan-Po Peng; Yungling Lee; Li-Min Huang; Luan-Yin Chang; Fu-Tong Liu
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

7.  IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis.

Authors:  Milica M Borovcanin; Slavica M Janicijevic; Ivan P Jovanovic; Nevena Gajovic; Nebojsa N Arsenijevic; Miodrag L Lukic
Journal:  Front Psychiatry       Date:  2018-06-22       Impact factor: 4.157

8.  Galectin-3 and incident cognitive impairment in REGARDS, a cohort of blacks and whites.

Authors:  Anand Venkatraman; Peter Callas; Leslie A McClure; Fred Unverzagt; Garima Arora; Virginia Howard; Virginia G Wadley; Mary Cushman; Pankaj Arora
Journal:  Alzheimers Dement (N Y)       Date:  2018-04-26

9.  Mice lacking galectin-3 (Lgals3) function have decreased home cage movement.

Authors:  Tammy R Chaudoin; Stephen J Bonasera
Journal:  BMC Neurosci       Date:  2018-05-02       Impact factor: 3.288

10.  Prevalence of mild cognitive impairment in type 2 diabetes mellitus is associated with serum galectin-3 level.

Authors:  Shizhan Ma; Shangbin Li; Renjun Lv; Xunyao Hou; Shanjing Nie; Qingqing Yin
Journal:  J Diabetes Investig       Date:  2020-04-28       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.